axogeninc.com (AXGN) Quarterly EPS earnings growth
AxoGen, Inc. (AXGN) maintains global leadership in nerve regeneration through its Avance platform, expanding its physician network without mergers. Quarterly EPS progress helps assess the sustainability of this growth, where 162.50 captures the current state of the parameter. The innovative approach is based on creating bio-scaffolds from donor tissues that restore patients' tactile sensitivity.
%20Year-over-year%20earnings%20per%20share%20growth%20for%20the%20last%2012%20months&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_AXGN_-_AxoGen-Inc._-_Year-over-year-earnings-per-share-growth-for-the-last-12-months "AXGN: axogeninc.com Year-over-year net earnings per share growth for the last 12 months 07/04/2022 - 11/10/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for AxoGen, Inc.
- share price and expert price forecast:
- market capitalization details:
- balance sheet net asset value indicators:
- debt and solvency information:
- earnings and valuation multiples information:
AXGN - Net Profit|Expected Profit AxoGen, Inc.|AXGN - Price to Earnings Ratio|Projected Price to Earnings Axogen Corp|AXGN - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Axogen Corp|AXGN - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Axogen|AXGN - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months axogeninc.com|AXGN - Earnings growth in current year|Earnings growth forecast for next year AxoGen, Inc.
Summary company analysis:Axogen - AXGN
Earnings per share dynamics serve as an indicator of capital management efficiency and the business's market value. The current quarterly EPS rate visualizes the rate of change in net income divided by the total number of shares. This metric measures the percentage deviation of the current result from the same period last year. For AxoGen, Inc. (AXGN), the stability of this figure confirms the resilience of demand for neurosurgical technologies. The low cyclicality of medical procedures protects the company's profitability from GDP fluctuations.
Competitors of AxoGen, Inc. (AXGN)
BSX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Edwards (EW)|RMD (ResMed Corp) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months PODD (Insulet Inc.)|Year-over-year net earnings per share growth for the last 12 months ZBH (Zimmer Biomet)|COO (coopercos.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Align Technology ALGN|GMED - Year-over-year net earnings per share growth for the last 12 months|TransMedics Organ Care System - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alphatec Corp|AORT: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ENOV|IART (Integra LifeSciences Holdings Corporation) - Quarterly EPS earnings growth|Establishment Labs Corp (ESTA) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BBNX|Year-over-year net earnings per share growth for the last 12 months IRADIMED Inc. IRMD|Quarterly EPS earnings growth EMBC (Embecta Corp.)|Quarterly EPS earnings growth tandemdiabetes.com TNDM|SIBN - Year-over-year earnings per share growth for the last twelve months|OFIX: Year-over-year earnings per share growth for the last twelve months|BVS (Bioventus Corp) - Year-over-year net earnings per share growth for the last 12 months|OrthoPediatrics - Year-over-year earnings per one share growth for the last 12 months|TMCI (Treace Medical Concepts) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months blade.com SRTA|Year-over-year earnings per share growth for the last twelve months Carlsmed (CARL)|RxSight Inc (RXST) - Net earnings per share growth for the trailing year|ClearPoint Neuro - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Stereotaxis Corporation STXS|Neuronetics, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months sightsciences.com SGHT|Orchestra BioMed (OBIO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ANIK (Anika Therapeutics, Inc.)|Year-over-year earnings per share growth for the last twelve months InspireMD Corp|Year-over-year net earnings per share growth for the last 12 months Jin Medical International Ltd (ZJYL)|Quarterly EPS earnings growth VANI|XTNT - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months NeuroOne Medical Technologies Corporation NMTC|MODD: Year-over-year earnings per share growth for the last 12 months|MYO: Year-over-year net earnings per share growth for the last 12 months|Envoy Medical Inc - Year-over-year earnings per share growth rate for the last twelve months|VVOS: Quarterly EPS earnings growth|envveno.com (NVNO) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months SINT|Year-over-year earnings per share growth for the last 12 months TNON (Tenon Medical Inc.)|Year-over-year earnings per share growth for the last twelve months ReWalk Robotics Ltd (LFWD)|AMIX - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth IVF (INVO Fertility Inc)|Net earnings per share growth for the trailing year bonebiologics.com|Axonics - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months BIOLASE Inc.|dynatronics.com (DYNT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months FNA|Year-over-year net earnings per share growth for the last 12 months INVO
